Business context and reporting period
Brand Engagement Network Inc. (BEN) filed this Form 10-K for the year ended December 31, 2023. A key limitation: the audited financial statements and MD&A in this filing are for DHC Acquisition Corp., the SPAC shell, not Legacy BEN, whose conversational-AI business became the combined company in March 2024. The filing says Legacy BEN’s audited 2023 and 2022 financial statements were to be included in a separate Form 8-K.
Legacy BEN describes a security-focused conversational-AI platform aimed initially at healthcare and automotive customers, with financial services as a potential expansion market. Its platform was in pilot development. The company reported its first healthcare customer in November 2023 and characterized revenue in 2023 and 2024 as minimal; the filing does not provide a clear revenue amount for Legacy BEN.
Financial results and liquidity
The following reported financial metrics relate to DHC, which had no operating business or operating revenue before the Business Combination.
| Metric | 2023 | 2022 |
|---|---|---|
| Operating costs | $2.81 million | $5.39 million |
| Net income (loss) | $(6.88) million | $7.21 million |
| Operating cash flow | $(0.82) million | $(0.65) million |
| Cash outside Trust Account at year-end | $40,167 | $212,608 |
| Cash and securities in Trust Account at year-end | $22.04 million | $313.91 million |
DHC’s 2023 loss included an $8.61 million non-redemption-agreement expense and $2.81 million of operating and formation costs, partly offset by $4.36 million of Trust Account interest and a $0.35 million gain from deferred underwriting-fee forgiveness. The prior-year profit included an $8.14 million favorable change in warrant fair value and $4.46 million of Trust Account interest; the year-over-year profit swing therefore does not represent operating growth. Operating margins are not meaningful for the shell company; no clear gross-margin figure is provided.
At December 31, 2023, DHC reported total liabilities of $8.78 million, including $8.02 million of current liabilities, a $0.33 million warrant liability, and a $0.43 million deferred underwriting fee. It reported a $7.98 million working-capital deficit. Cash and securities held in the Trust Account were largely subject to the SPAC transaction/redemption process and should not be treated as unrestricted operating liquidity.
After year-end, the March 14, 2024 Business Combination generated stated net proceeds of $7.1 million, inclusive of remaining Trust Account cash and private-placement proceeds, before transaction and issuance costs. The filing says cash would fund transaction expenses, operations, and working capital. Despite the transaction, management and the auditor cited substantial doubt about the company’s ability to continue as a going concern; management intends to raise additional capital.
Material changes and unusual items
- DHC’s Trust Account fell from $313.91 million at year-end 2022 to $22.04 million at year-end 2023, principally following shareholder redemptions. In March 2023, redemptions totaled approximately $268.59 million; further redemptions occurred in December 2023 and at the 2024 closing.
- The 2023 financial statements reflect a restatement of previously reported quarterly amounts related to the fair value of founder shares promised under non-redemption agreements. The filing corrects the number of shares associated with the February 2023 agreement and records non-redemption expense; prior Forms 10-Q were not amended, with historical amounts to be recast prospectively in later filings.
- A Trust Account trustee error caused an $887,555 overpayment to redeeming shareholders. DHC had collected $870,731 by year-end and reported $16,824 receivable, which it expected to recover.
- In November 2023, Citi waived most of its deferred underwriting fee; $10.40 million was derecognized, with the accounting allocation reflected partly in equity and partly as a gain. A remaining $433,231 payable was reported at year-end.
- The March 2024 Business Combination is accounted for as a reverse recapitalization, with Legacy BEN as the accounting predecessor. It is a subsequent event, not part of DHC’s 2023 operating results.
Outlook, risks, and controls
No quantified revenue, earnings, or cash-flow guidance is provided. BEN’s plans include expanding pilots and customer acquisition through direct sales and channel partners, growing automotive and healthcare offerings, and potentially entering financial services and other markets. AFG received exclusive reseller rights for specified automotive products under a five-year agreement. These plans depend on converting pilots into recurring contracts, building a customer base, and obtaining financing.
Principal risks include limited operating history and minimal Legacy BEN revenue; expected losses and need for additional capital; dependence on a small number of customers and channel partners; long and uncertain sales cycles; intense AI competition; reliance on third-party technology and cloud services; AI accuracy, bias, privacy, security, and regulatory risks; and potential dilution from future financing. The filing also identifies significant uncertainty around the market opportunity and customer return on investment.
Management found disclosure controls and internal control over financial reporting ineffective as of December 31, 2023. The filing describes multiple material weaknesses involving control documentation, accounting resources, merger and equity accounting, and liability classification, as well as significant deficiencies. Remediation efforts included hiring a CFO and adding review procedures, but the weaknesses had not been remediated. The auditor gave an unqualified opinion on the DHC financial statements while highlighting the going-concern uncertainty; the auditor did not opine on control effectiveness.
The filing reports no legal proceeding expected to have a material adverse effect. It also notes prior Nasdaq compliance notices concerning the annual-meeting requirement and SPAC business-combination deadline; the company expected the latter issue to be resolved by closing, but continued listing compliance remained a stated risk.
Most important facts for investors to verify
- Review Legacy BEN’s audited 2023 and 2022 financial statements in the separate Form 8-K, including actual revenue, losses, cash flows, and balance-sheet liquidity; the figures in this 10-K’s audited statements are DHC’s, not the operating company’s.
- Confirm the combined company’s post-closing unrestricted cash, transaction expenses, remaining obligations, and financing runway; the filing states that liquidity remained unstable and substantial doubt existed about going concern.
- Check whether Legacy BEN’s pilots and first healthcare customer converted into material, recurring revenue, and assess customer concentration and AFG channel performance.
- Track remediation of material weaknesses and significant deficiencies, and whether later filings require further recasting or correction of historical results.
- Assess dilution, lock-up expirations, warrant overhang, and ongoing Nasdaq listing compliance.